Immunity and Immune Evasion Mechanisms of Epstein–Barr Virus
Authors:
- 1 June 2023
- journal article
- research article
- Published by SAGE Publications in Viral Immunology
- Vol. 36 (5) , 303-317
Abstract
Epstein–Barr virus (EBV) is the first human oncogenic virus to be identified, which evades the body's immune surveillance through multiple mechanisms that allow long-term latent infection. Under certain pathological conditions, EBVs undergo a transition from the latent phase to the lytic phase and cause targeted dysregulation of the host immune system, leading to the development of EBV-related diseases. Therefore, an in-depth understanding of the mechanism of developing an immune response to EBV and the evasion of immune recognition by EBV is important for the understanding of the pathogenesis of EBV, which is of great significance for finding strategies to prevent EBV infection, and developing a therapy to treat EBV-associated diseases. In this review, we will discuss the molecular mechanisms of host immunological responses to EBV infection and the mechanisms of EBV-mediated immune evasion during chronic active infection.Keywords
This publication has 121 references indexed in Scilit:
- Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus ReceptorCell Reports, 2013
- Tumour inflammasome‐derived IL‐1β recruits neutrophils and improves local recurrence‐free survival in EBV‐induced nasopharyngeal carcinomaEMBO Molecular Medicine, 2012
- Multipronged attenuation of macrophage-colony stimulating factor signaling by Epstein–Barr virus BARF1Proceedings of the National Academy of Sciences, 2012
- Cytokine Homologs of Human GammaherpesvirusesJournal of Interferon & Cytokine Research, 2012
- Immune Signaling by RIG-I-like ReceptorsImmunity, 2011
- Epstein–Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-βVirology, 2010
- Pattern Recognition Receptors and InflammationCell, 2010
- Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3Journal of Experimental Medicine, 2009
- RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I PathwayCell, 2009
- EB virus‐encoded RNAs are recognized by RIG‐I and activate signaling to induce type I IFNThe EMBO Journal, 2006